|1.||Abramić, Marija: 6 articles (01/2012 - 10/2003)|
|2.||Vukelić, Bojana: 3 articles (01/2012 - 03/2007)|
|3.||Agić, Dejan: 3 articles (01/2012 - 04/2007)|
|4.||Spoljarić, Jasminka: 3 articles (09/2011 - 03/2007)|
|5.||Jajcanin, Nina: 3 articles (02/2008 - 03/2007)|
|6.||Chauhan, Shyam S: 2 articles (03/2014 - 04/2010)|
|7.||Salopek-Sondi, Branka: 2 articles (01/2012 - 02/2008)|
|8.||Simaga, Sumski: 2 articles (02/2008 - 10/2003)|
|9.||Singh, Ratnakar: 1 article (03/2014)|
|10.||Sharma, Mehar C: 1 article (03/2014)|
01/01/2012 - "Dipeptidyl peptidase III (DPP III), a member of the metallopeptidase family M49, was considered as an exclusively eukaryotic enzyme involved in intracellular peptide catabolism and pain modulation. "
02/01/2008 - "Abstract Human dipeptidyl peptidase III (DPP III) is a member of the metallopeptidase family M49 with an implied role in the pain-modulatory system and endogenous defense against oxidative stress. "
04/24/2012 - "Dipeptidyl peptidase III (DPP III) is one of the most important enkephalin-degrading enzymes associated with the mammalian pain modulatory system. "
09/01/2011 - "Human dipeptidyl peptidase III (DPP III) is a zinc-exopeptidase with implied roles in protein catabolism, pain modulation, and defense against oxidative stress. "
04/01/2007 - "Dipeptidyl peptidase III (DPP III), also known as enkephalinase B, is a zinc-hydrolase with an indicated role in the mammalian pain modulatory system. "
|2.||Glioblastoma (Glioblastoma Multiforme)
07/01/1985 - "Exopeptidases identified as dipeptidyl peptidase III and leucine aminopeptidase, and an endopeptidase, prolyl endopeptidase, were found in the Emory Mouse cataract and the Cataract Resistant mouse lens extracts. "
09/01/2001 - "The role of proteolytic enzymes in Shumiya cataract rats in alterations to lens proteins during cataract formation was studied immunohistochemically using antibodies against exopeptidases, such as lysosomal dipeptidyl peptidase II (DPP II), cytosolic dipeptidyl peptidase III, and soluble and membrane-bound alanyl aminopeptidases, and against cytosolic endopeptidases such as mu- and m-calpains, and 20S proteasome. "
|4.||Endometrial Neoplasms (Endometrial Cancer)
|5.||Substance Withdrawal Syndrome (Withdrawal Symptoms)
07/01/1987 - "Intracerebroventricular administration of phelorphan (158 nmol/2 microliters), a blocker of dipeptidylaminopeptidase (enkephalinase B) and other enzymes involved in the enkephalin biodegradation, inhibited in chronic morphine-dependent rats, the occurrence of some of the naloxone-precipitated withdrawal symptoms. "
|5.||dipeptidyl peptidase III
|6.||Proteasome Endopeptidase Complex (Proteasome)
|7.||Interleukin-6 (Interleukin 6)
|8.||Transcription Factors (Transcription Factor)
|10.||Peptide Hydrolases (Proteases)